Literature DB >> 7933137

Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection.

D McKenzie1, J Kaczkowski, R Marsh, J Aiken.   

Abstract

Amphotericin B delays the onset of clinical symptoms in hamsters infected with scrapie agent strain 263K. Here we show that accumulation of a scrapie-specific isoform of the prion protein (PrP-res) and agent replication were delayed early in amphotericin B-treated animals. By 8 weeks postinfection, only untreated animals exhibited clinical symptoms of scrapie infection whereas PrP-res levels and titers were similar in treated and untreated animals. This suggests that although PrP-res accumulation and agent replication are linked, they are not the sole factors required for the onset of clinical disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933137      PMCID: PMC237196     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

Review 1.  Scrapie strain variation and its implications.

Authors:  M E Bruce; H Fraser
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

2.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Isolation and structural studies of the intact scrapie agent protein.

Authors:  D C Bolton; P E Bendheim; A D Marmorstein; A Potempska
Journal:  Arch Biochem Biophys       Date:  1987-11-01       Impact factor: 4.013

5.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

6.  Linkage of the scrapie-associated fibril protein (PrP) gene and Sinc using congenic mice and restriction fragment length polymorphism analysis.

Authors:  N Hunter; J Hope; I McConnell; A G Dickinson
Journal:  J Gen Virol       Date:  1987-10       Impact factor: 3.891

7.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.

Authors:  Y G Xi; L Ingrosso; A Ladogana; C Masullo; M Pocchiari
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters.

Authors:  M Pocchiari; S Schmittinger; C Masullo
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

View more
  14 in total

1.  Branched polyamines cure prion-infected neuroblastoma cells.

Authors:  S Supattapone; H Wille; L Uyechi; J Safar; P Tremblay; F C Szoka; F E Cohen; S B Prusiner; M R Scott
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.

Authors:  R Demaimay; K T Adjou; V Beringue; S Demart; C I Lasmézas; J P Deslys; M Seman; D Dormont
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.

Authors:  K T Adjou; R Demaimay; C Lasmezas; J P Deslys; M Seman; D Dormont
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

4.  Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons.

Authors:  R Demaimay; R Race; B Chesebro
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform.

Authors:  K Kaneko; M Vey; M Scott; S Pilkuhn; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

7.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 8.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

9.  Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice.

Authors:  Daryl S Spinner; In Soo Cho; Seung Yong Park; Jae Il Kim; Harry C Meeker; Xuemin Ye; Giuseppe Lafauci; Daniel J Kerr; Michael J Flory; Bo Sook Kim; Regina B Kascsak; Thomas Wisniewski; William R Levis; Georgia B Schuller-Levis; Richard I Carp; Eunkyue Park; Richard J Kascsak
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  The association between PrP and infectivity in scrapie and BSE infected mouse brain.

Authors:  R A Somerville; A J Dunn
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.